The establishment of Moderna’s Korean subsidiary has begun. Moderna's business team from its U.S. headquarters had visited a factory of a domestic pharmaceutical company. The company's actions are adding strength to the speculation that domestic production of Moderna's vaccines is imminent.

The factory that the business team had visited the previous month is expected to act as an outpost for Moderna’s vaccine production. On this, various scenarios on whether Moderna will directly take charge of vaccine production in Korea or will contract a domestic company to produce the vaccine are being raised in the industry.

◆'Establishment of ‘Moderna Korea’ … why enter Korea?<